VeriSign Q3 EPS, Revenue Increase-February 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

VeriSign Q3 EPS, Revenue Increase

Nov 3, 2024 11:08 AM

04:51 PM EDT, 10/24/2024 (MT Newswires) -- VeriSign ( VRSN ) reported Q3 earnings Thursday of $2.07 per diluted share, up from $1.83 a year earlier.

A lone analyst polled by Capital IQ expected $1.99.

Revenue in the three months ended Sept. 30 rose to $390.6 million from $376.3 million a year earlier.

Two analysts surveyed by Capital IQ expected $390.2 million.

Price: 185.33, Change: +0.21, Percent Change: +0.11

Previous page： Westgold's Updated 2025 Mineral Resource and Ore Reserves Show Increase; Shares at 52 Week Highs Next page： Top Premarket Decliners

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Westgold's Updated 2025 Mineral Resource and Ore Reserves Show Increase; Shares at 52 Week Highs

Sep 3, 2025

07:41 AM EDT, 09/03/2025 (MT Newswires) -- Westgold Resources ( WGXRF ) , which gained 7.4% to 52 week highs yesterday, overnight Tuesday said the updated mineral resource estimate (MRE) and ore reserve statement for the Murchison and Southern Goldfields operations showed an increase in resources. Among highlights, WGX said the report shows a 24% increase in mineral resource from...

Top Premarket Decliners

Sep 3, 2025

07:42 AM EDT, 09/03/2025 (MT Newswires) -- Connexa Sports Technologies ( YYAI ) stock was down 11% pre-bell Wednesday, adding to losses from the previous session. Skillz ( SKLZ ) shares were 10% lower following a 1.3% decrease. CleanCore Solutions ( ZONE ) stock was down 9.6%, extending Tuesday's slide. ...

Nuveen partners with Hunter Point and Temasek for private credit push

Sep 3, 2025

(Reuters) -Investment manager Nuveen's private debt arm has partnered with Hunter Point Capital and Temasek, the company said on Wednesday, as it furthers its push into the fast-growing slice of corporate financing market. Under the agreement, Hunter Point and Temasek will make minority investments in Nuveen Private Capital. Singapore-based Temasek will also provide long-term capital commitments to Nuveen's new and...

Novartis signs up to $5.2 billion heart drugs licensing deal with China's Argo

Sep 3, 2025

Sept 3 (Reuters) - Swiss drugmaker Novartis has signed an up to $5.2 billion licensing and options deal with Argo Biopharmaceutical for its experimental cardiovascular drugs, the China-based biotech said on Wednesday. The deal includes an experimental genetic medicine in mid-stage study to control high blood fat levels and an option to license two drug candidates for high levels of...